IDEAS home Printed from https://ideas.repec.org/p/zbw/oefseb/32.html
   My bibliography  Save this paper

COVID-19 und das Versagen pharmazeutischer Innovation für den globalen Süden: Das Beispiel der "vernachlässigten Krankheiten" und der Neuen Infektionskrankheiten

Author

Listed:
  • Raza, Werner G.

Abstract

Die Debatte um den mangelnden Zugang zu COVID-19-Impfstoffen für die Länder des Globalen Südens reiht sich ein in eine lange Geschichte des Kampfs um effektive und leistbare Behandlungen für jene mehrere Dutzend Krankheiten, für die von der Weltgesundheitsorganisation (WHO) das bezeichnende Adjektiv "vernachlässigt" verwendet wird. Die empirische Evidenz zeigt, dass das in den letzten dreißig Jahren zentral um den globalen Schutz sogenannter geistiger Eigentumsrechte aufgebaute pharmazeutische Innovationssystem hier breitflächig versagt hat. Ähnliches gilt für die Kategorie der Neuen Infektionskrankheiten, die auch die Coronaviren umfasst. Auch hier gab es nur geringe Forschungs- und Entwicklungsanstrengungen, obwohl die Gefahren der dadurch ausgelösten Erkrankungen seit 20 Jahren bekannt waren. Die COVID-19 Pandemie sollte daher für eine grundlegende Reform genutzt werden mit dem Ziel, die pharmazeutische Innovation stärker an öffentlichen Gesundheitszielen auszurichten. Neben stärkerem finanziellen Engagement der EU sollte auch von der Pharmaindustrie ein größerer Beitrag zur Bekämpfung dieser Krankheiten verlangt werden, zum Beispiel in Form einer Abgabe zur Finanzierung von Forschung und Entwicklung (F&E) für "vernachlässigte Krankheiten" und Neue Infektionskrankheiten.

Suggested Citation

  • Raza, Werner G., 2021. "COVID-19 und das Versagen pharmazeutischer Innovation für den globalen Süden: Das Beispiel der "vernachlässigten Krankheiten" und der Neuen Infektionskrankheiten," Briefing Papers 32, Austrian Foundation for Development Research (ÖFSE).
    • Handle: RePEc:zbw:oefseb:32
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/232583/1/1752675223.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Lanjouw, Jean O & Schankerman, Mark, 2004. "Protecting Intellectual Property Rights: Are Small Firms Handicapped?," Journal of Law and Economics, University of Chicago Press, vol. 47(1), pages 45-74, April.
    2. Ha-Joon Chang, 2001. "Intellectual Property Rights and Economic Development: Historical lessons and emerging issues," Journal of Human Development and Capabilities, Taylor & Francis Journals, vol. 2(2), pages 287-309.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Elisabeth Christen, 2021. "America is back. Chancen und Herausforderungen für die multilaterale Zusammenarbeit," FIW Policy Brief series 053, FIW.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Raza, Werner G., 2021. "COVID-19 and the failure of pharmaceutical innovation for the global South: The example of "neglected diseases" and emerging infectious diseases," Briefing Papers 32a, Austrian Foundation for Development Research (ÖFSE).
    2. Galasso, Alberto & Schankerman, Mark, 2013. "Patents and Cumulative Innovation:Causal Evidence from the Courts," IIR Working Paper 13-16, Institute of Innovation Research, Hitotsubashi University.
    3. Schankerman, Mark & Schuett, Florian, 2016. "Screening for Patent Quality," CEPR Discussion Papers 11688, C.E.P.R. Discussion Papers.
    4. Dietmar Harhoff & Georg von Graevenitz & Stefan Wagner, 2016. "Conflict Resolution, Public Goods, and Patent Thickets," Management Science, INFORMS, vol. 62(3), pages 704-721, March.
    5. Alberto Galasso & Mark Schankerman, 2008. "Patent Thickets and the Market for Innovation: Evidence from Settlement of Patent Disputes," CEP Discussion Papers dp0889, Centre for Economic Performance, LSE.
    6. Dolfsma, W.A., 2006. "IPRs, Technological Development, and Economic Development," ERIM Report Series Research in Management ERS-2006-004-ORG, Erasmus Research Institute of Management (ERIM), ERIM is the joint research institute of the Rotterdam School of Management, Erasmus University and the Erasmus School of Economics (ESE) at Erasmus University Rotterdam.
    7. Michael Noel & Mark Schankerman, 2013. "Strategic Patenting and Software Innovation," Journal of Industrial Economics, Wiley Blackwell, vol. 61(3), pages 481-520, September.
    8. Figueroa, Nicolás & Serrano, Carlos J., 2019. "Patent trading flows of small and large firms," Research Policy, Elsevier, vol. 48(7), pages 1601-1616.
    9. Koki Oikawa & Minoru Kitahara, 2017. "Technology Polarization," Working Papers e113, Tokyo Center for Economic Research.
    10. Graham, Stuart J.H. & Harhoff, Dietmar, 2014. "Separating patent wheat from chaff: Would the US benefit from adopting patent post-grant review?," Research Policy, Elsevier, vol. 43(9), pages 1649-1659.
    11. Carlos J. Serrano & Rosemarie Ziedonis, 2018. "How Redeployable are Patent Assets? Evidence from Failed Startups," NBER Working Papers 24526, National Bureau of Economic Research, Inc.
    12. Boeing, Philipp & Mueller, Elisabeth, 2019. "Measuring China's patent quality: Development and validation of ISR indices," China Economic Review, Elsevier, vol. 57(C).
    13. Juranek, Steffen & Otneim, Håkon, 2021. "Using machine learning to predict patent lawsuits," Discussion Papers 2021/6, Norwegian School of Economics, Department of Business and Management Science.
    14. Ryan, Michael P., 2010. "Patent Incentives, Technology Markets, and Public-Private Bio-Medical Innovation Networks in Brazil," World Development, Elsevier, vol. 38(8), pages 1082-1093, August.
    15. Karin Beukel & Minyuan Zhao, 2018. "IP litigation is local, but those who litigate are global," Journal of International Business Policy, Palgrave Macmillan, vol. 1(1), pages 53-70, June.
    16. Gerard Llobet & Javier Suarez, 2005. "Financing and the Protection of Innovators," Working Papers wp2005_0502, CEMFI.
    17. Mazzeo, Michael J. & Hillel, Jonathan & Zyontz, Samantha, 2013. "Explaining the “unpredictable”: An empirical analysis of U.S. patent infringement awards," International Review of Law and Economics, Elsevier, vol. 35(C), pages 58-72.
    18. Andreas Panagopoulos & In-Uck Park, 2008. "Patent Protection, Takeovers, and Startup Innovation: A Dynamic Approach," The Centre for Market and Public Organisation 08/201, The Centre for Market and Public Organisation, University of Bristol, UK.
    19. Popov, V., 2011. "Do We Need to Protect Intellectual Property Rights?," Journal of the New Economic Association, New Economic Association, issue 11, pages 107-126.
    20. Schankerman, Mark & Schütt, Florian, 2016. "Screening for Patent Quality : Examination, Fees, and the Courts," Other publications TiSEM fa319822-6e68-4e05-8547-4, Tilburg University, School of Economics and Management.

    More about this item

    Keywords

    TRIPS-Abkommen; COVID-19; Patente; vernachlässigte Krankheiten; Neue Infektionskrankheiten;
    All these keywords.

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:oefseb:32. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/ofsewat.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.